These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 37947590)

  • 1. Detrimental Effects of ApoE ε4 on Blood-Brain Barrier Integrity and Their Potential Implications on the Pathogenesis of Alzheimer's Disease.
    Kirchner K; Garvert L; Kühn L; Bonk S; Grabe HJ; Van der Auwera S
    Cells; 2023 Oct; 12(21):. PubMed ID: 37947590
    [TBL] [Abstract][Full Text] [Related]  

  • 2. How does apolipoprotein E genotype influence the relationship between physical activity and Alzheimer's disease risk? A novel integrative model.
    de Frutos Lucas J; Sewell KR; García-Colomo A; Markovic S; Erickson KI; Brown BM
    Alzheimers Res Ther; 2023 Jan; 15(1):22. PubMed ID: 36707869
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apolipoprotein E-epsilon4 alleles in cerebral amyloid angiopathy and cerebrovascular pathology associated with Alzheimer's disease.
    Premkumar DR; Cohen DL; Hedera P; Friedland RP; Kalaria RN
    Am J Pathol; 1996 Jun; 148(6):2083-95. PubMed ID: 8669492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does the imbalance in the apolipoprotein E isoforms underlie the pathophysiological process of sporadic Alzheimer's disease?
    Lozupone M; Imbimbo BP; Balducci C; Lo Vecchio F; Bisceglia P; Latino RR; Leone M; Dibello V; Solfrizzi V; Greco A; Daniele A; Watling M; Seripa D; Panza F
    Alzheimers Dement; 2023 Jan; 19(1):353-368. PubMed ID: 35900209
    [TBL] [Abstract][Full Text] [Related]  

  • 5. APOE ε4, Alzheimer's disease neuropathology and sleep disturbance, in individuals with and without dementia.
    Blackman J; Love S; Sinclair L; Cain R; Coulthard E
    Alzheimers Res Ther; 2022 Mar; 14(1):47. PubMed ID: 35354468
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apolipoprotein E genotype and the diagnostic accuracy of cerebrospinal fluid biomarkers for Alzheimer disease.
    Lautner R; Palmqvist S; Mattsson N; Andreasson U; Wallin A; Pålsson E; Jakobsson J; Herukka SK; Owenius R; Olsson B; Hampel H; Rujescu D; Ewers M; Landén M; Minthon L; Blennow K; Zetterberg H; Hansson O;
    JAMA Psychiatry; 2014 Oct; 71(10):1183-91. PubMed ID: 25162367
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apolipoprotein E, especially apolipoprotein E4, increases the oligomerization of amyloid β peptide.
    Hashimoto T; Serrano-Pozo A; Hori Y; Adams KW; Takeda S; Banerji AO; Mitani A; Joyner D; Thyssen DH; Bacskai BJ; Frosch MP; Spires-Jones TL; Finn MB; Holtzman DM; Hyman BT
    J Neurosci; 2012 Oct; 32(43):15181-92. PubMed ID: 23100439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fragmentation of brain apolipoprotein E (ApoE) and its relevance in Alzheimer's disease.
    Amponsah AE; Feng B; Guo R; Zhang W; He J; Kong D; Dong T; Ma J; Cui H
    Rev Neurosci; 2020 Aug; 31(6):589-603. PubMed ID: 32364519
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blood and brain transcriptome analysis reveals APOE genotype-mediated and immune-related pathways involved in Alzheimer disease.
    Panitch R; Hu J; Xia W; Bennett DA; Stein TD; Farrer LA; Jun GR
    Alzheimers Res Ther; 2022 Feb; 14(1):30. PubMed ID: 35139885
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Associations of circulating C-reactive proteins, APOE ε4, and brain markers for Alzheimer's disease in healthy samples across the lifespan.
    Wang Y; Grydeland H; Roe JM; Pan M; Magnussen F; Amlien IK; Watne LO; Idland AV; Bertram L; Gundersen TE; Pascual-Leone A; Cabello-Toscano M; Tormos JM; Bartres-Faz D; Drevon CA; Fjell AM; Walhovd KW
    Brain Behav Immun; 2022 Feb; 100():243-253. PubMed ID: 34920091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peripheral versus central nervous system APOE in Alzheimer's disease: Interplay across the blood-brain barrier.
    Chernick D; Ortiz-Valle S; Jeong A; Qu W; Li L
    Neurosci Lett; 2019 Aug; 708():134306. PubMed ID: 31181302
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Linking APOE-ε4, blood-brain barrier dysfunction, and inflammation to Alzheimer's pathology.
    Riphagen JM; Ramakers IHGM; Freeze WM; Pagen LHG; Hanseeuw BJ; Verbeek MM; Verhey FRJ; Jacobs HIL
    Neurobiol Aging; 2020 Jan; 85():96-103. PubMed ID: 31733942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential Effects of the Interaction Between the Education and APOE ε4 Allele on Amyloid-beta Retention and Memory Performances in Cognitively Normal Older Adults and Alzheimer's Disease Patients.
    Kang DW; Wang SM; Na HR; Lee CU; Baek IH; Lim HK
    Curr Alzheimer Res; 2020; 17(11):1023-1032. PubMed ID: 33372875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cerebrospinal fluid beta-amyloid1-42 and tau in control subjects at risk for Alzheimer's disease: the effect of APOE epsilon4 allele.
    Sunderland T; Mirza N; Putnam KT; Linker G; Bhupali D; Durham R; Soares H; Kimmel L; Friedman D; Bergeson J; Csako G; Levy JA; Bartko JJ; Cohen RM
    Biol Psychiatry; 2004 Nov; 56(9):670-6. PubMed ID: 15522251
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of
    Xicota L; Gyorgy B; Grenier-Boley B; Lecoeur A; Fontaine G; Danjou F; Gonzalez JS; Colliot O; Amouyel P; Martin G; Levy M; Villain N; Habert MO; Dubois B; Lambert JC; Potier MC;
    Neurology; 2022 Aug; 99(5):e462-e475. PubMed ID: 35606148
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apolipoprotein E regulates the integrity of tight junctions in an isoform-dependent manner in an in vitro blood-brain barrier model.
    Nishitsuji K; Hosono T; Nakamura T; Bu G; Michikawa M
    J Biol Chem; 2011 May; 286(20):17536-42. PubMed ID: 21471207
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blocking the apoE/Aβ interaction ameliorates Aβ-related pathology in APOE ε2 and ε4 targeted replacement Alzheimer model mice.
    Pankiewicz JE; Guridi M; Kim J; Asuni AA; Sanchez S; Sullivan PM; Holtzman DM; Sadowski MJ
    Acta Neuropathol Commun; 2014 Jun; 2():75. PubMed ID: 24972680
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apolipoprotein E controls cerebrovascular integrity via cyclophilin A.
    Bell RD; Winkler EA; Singh I; Sagare AP; Deane R; Wu Z; Holtzman DM; Betsholtz C; Armulik A; Sallstrom J; Berk BC; Zlokovic BV
    Nature; 2012 May; 485(7399):512-6. PubMed ID: 22622580
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apolipoprotein E, amyloid-beta, and blood-brain barrier permeability in Alzheimer disease.
    Donahue JE; Johanson CE
    J Neuropathol Exp Neurol; 2008 Apr; 67(4):261-70. PubMed ID: 18379441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. APOE ε4-dependent effects on the early amyloid pathology in induced neurons of patients with Alzheimer's disease.
    Kim H; Kim S; Cho B; Shin J; Kim J
    Transl Neurodegener; 2022 Oct; 11(1):45. PubMed ID: 36284363
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.